Ronald Blue Trust, Inc. Bio N Tech Se Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Bio N Tech Se stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 467 shares of BNTX stock, worth $54,821. This represents 0.0% of its overall portfolio holdings.
Number of Shares
467
Previous 79
491.14%
Holding current value
$54,821
Previous $6,000
816.67%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BNTX
# of Institutions
357Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.31MShares$975 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$530 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$512 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$223 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$212 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $28.5B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...